MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Anika Therapeutics Company Profile (NASDAQ:ANIK)

Consensus Ratings for Anika Therapeutics (NASDAQ:ANIK) (?)
Ratings Breakdown: 2 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $49.50 (3.11% downside)

Analysts' Ratings History for Anika Therapeutics (NASDAQ:ANIK)
Show:
DateFirmActionRatingPrice TargetActions
4/27/2016Northland SecuritiesDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016Barrington ResearchBoost Price TargetOutperform$45.00 -> $49.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/27/2015First AnalysisInitiated CoverageEqual -> Equal WeightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/12/2014Singular ResearchLower Price TargetBUY -> Buy$51.50 -> $45.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/26/2014 forward)
Earnings History for Anika Therapeutics (NASDAQ:ANIK)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/27/2016        
4/27/2016Q116$0.28$0.45$19.26 million$22.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2016Q415$0.60$0.72$28.19 million$25.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2015Q315$0.34$0.55$22.36 million$23.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2015Q215$0.34$0.51$21.65 million$22.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2015Q115$0.21$0.23$16.20 million$15.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2015Q414$0.48$0.51$24.60 million$23.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q314$0.33$0.40$20.33 million$22.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2014Q214$0.57$0.60$28.20 million$26.27 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2014Q114$0.25$0.97$16.03 million$34.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2014Q413$0.42$0.44$21.91 million$21.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/31/2013Q313$0.14$0.33$16.96 million$17.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2013Q2 2013$0.25$0.40$17.09 million$20.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Anika Therapeutics (NASDAQ:ANIK)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.19$0.25$0.22
Q2 20162$0.38$0.47$0.43
Q3 20162$0.38$0.47$0.43
Q4 20162$0.41$0.47$0.44
(Data provided by Zacks Investment Research)
Dividend History for Anika Therapeutics (NASDAQ:ANIK)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Anika Therapeutics (NASDAQ:ANIK)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
2/25/2016Raymond J LandDirectorSell2,695$43.62$117,555.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/27/2015Raymond J LandDirectorSell4,621$39.49$182,483.29View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2014Charles H SherwoodCEOSell83,780$44.32$3,713,129.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/28/2014Charles H SherwoodCEOSell200,000$41.70$8,340,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/22/2013John C MoranDirectorSell5,000$24.35$121,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/8/2013Steve E WheelerDirectorSell26,984$23.61$637,092.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2013Steve E WheelerDirectorSell11,016$27.01$297,542.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/6/2013Farmaceutici S.P.A. FidiaMajor ShareholderSell1,270,000$24.52$31,140,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2013Charles H SherwoodCEOSell75,000$20.11$1,508,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/9/2013Charles H SherwoodCEOSell49,185$18.06$888,281.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/5/2013Charles H SherwoodCEOSell34,662$18.01$624,262.62View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/19/2013Charles H SherwoodCEOSell1,847$18.00$33,246.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Anika Therapeutics (NASDAQ:ANIK)
DateHeadline
06/24/16 02:29 PMAnika Therapeutics Inc. (NASDAQ:ANIK) Yearly Sales Target At $114.76 - Investor Newswire
06/24/16 02:29 PMAnika Therapeutics Inc. versus ATRION Corp. Head to Head Compare - CML News
06/24/16 09:10 AMNew study: Global non surgical bio implants market 2015 analysis and forecast to 2022
06/23/16 03:57 PMAlere Inc. versus Anika Therapeutics Inc. Head to Head Compare - CML News
06/22/16 07:40 PMAnika Therapeutics Inc. (ANIK) Hits New 52-week High During June 21 Session - Equities.com
06/21/16 07:15 AMRecently Issued Stock Ratings For Anika Therapeutics Inc. (NASDAQ:ANIK) - Fiscal Standard
06/20/16 08:58 AMMoving Stocks: Anika Therapeutics Inc. (NASDAQ:ANIK), Sirius XM Holdings Inc. (NASDAQ:SIRI), Optibase Ltd ... - KC Register
06/19/16 02:27 PMAnika Therapeutics Inc. (NASDAQ:ANIK) Analyst Price Targets For The Coming Week - Fiscal Standard
06/18/16 07:13 AMAnika Therapeutics Inc. (ANIK) Hits New 52-week High During June 15 Session - Equities.com
06/16/16 07:52 PMAnika Therapeutics Inc. (NASDAQ:ANIK) Yearly Sales Projections At $114.76 - Investor Newswire
06/16/16 04:56 AMAnika Therapeutics Inc. (ANIK) Hits New 52-week High During June 14 Session - Equities.com
06/15/16 02:32 PMAnika Therapeutics Inc. (ANIK) Hits New 52-week High During June 13 Session - Equities.com
06/14/16 02:30 PMCombination Therapies in Aesthetics Market : Global Industry Analysis and Forecast 2016 - 2026
06/14/16 07:17 AMTesla Motors Inc (NASDAQ:TSLA) Decreased-4.61%: Anika Therapeutics Inc. (NASDAQ:ANIK), Micron Technology, Inc ... - KC Register
06/09/16 08:26 PMAnika Therapeutics Inc. (NASDAQ:ANIK) Fundamental Star Rating Report - CML News
06/08/16 10:56 AMANIKA THERAPEUTICS INC. (NASDAQ:ANIK) Financial Condition Compared to S&P 500 - CML News
06/06/16 03:06 PMANIKA THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/06/16 12:03 PMAnika Therapeutics Inc. (NASDAQ:ANIK) Has $1.6 Millions Outstanding Debt Accrued - RealistInvestor.com
06/05/16 07:47 PMAfter Last Week What Do Analysts Think Of Anika Therapeutics Inc. (NASDAQ:ANIK) - Share Trading News
06/04/16 07:49 PMAre Analysts Bearish Anika Therapeutics Inc (NASDAQ:ANIK) After Last Week? - HNN
06/03/16 08:34 PMAnika Therapeutics Inc. (NASDAQ:ANIK) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News
06/02/16 03:45 PMAnika to Present at the Singular Research 11th Annual Spring Select Conference on June 9, 2016 - [at noodls] - 2adc72e7-90c7-4ace-91aa-4ccf68602199.pdf June 2, 2016 BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics ...
06/01/16 02:31 PMBRIEF-Anika Therapeutics announces European commercial launch of Cingal - Reuters - BRIEF-Anika Therapeutics announces European commercial launch of CingalReutersBRIEF-Anika Therapeutics announces European commercial launch of Cingal. June 1 Anika Therapeutics Inc. * Anika announces European commercial launch of Cingal for the treatment of pain associated with osteoarthritis Source text for Eikon: Further ...
06/01/16 10:55 AMAnika Reveals Commercial Launch Of CINGAL In Europe - Benzinga - Anika Reveals Commercial Launch Of CINGAL In EuropeBenzingaAnika Therapeutics, Inc. ANIK 0.54% revealed the commercial launch of CINGAL, its third-generation viscosupplement, in the European Union. According to the company, CINGAL, which would be initially available in Hungary, Czech Republic, Poland, ...Buy, Sell Or Hold Rating For Anika Therapeutics Inc. (NASDAQ:ANIK)?Share Trading NewsStock Trending Up: Anika Therapeutics Inc. (NASDAQ:ANIK)The PostAnika Therapeutics (NASDAQ:ANIK) announces European commercial launch of Cingal: Stone Energy (NYSE:SGY ...Benchmark MonitorStreetInsider.comall 5 news articles »
06/01/16 09:31 AMAnika Reveals Commercial Launch Of CINGAL In Europe -
06/01/16 08:23 AMAnika Announces European Commercial Launch of CINGAL for the Treatment of Pain Associated with Osteoarthritis - [at noodls] - 986f5fe2-690b-4e1d-b2d6-7bbab2eba986.pdf June 1, 2016 BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics ...
05/29/16 07:44 AMAre Analysts Bullish Anika Therapeutics Inc (NASDAQ:ANIK) After Last Week? - HNN - Are Analysts Bullish Anika Therapeutics Inc (NASDAQ:ANIK) After Last Week?HNNOut of 4 analysts covering Anika Therapeutics (NASDAQ:ANIK), 2 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 50% are positive. Anika Therapeutics has been the topic of 6 analyst reports since July 30, 2015 according to StockzIntelligence Inc ...
05/27/16 05:07 PMHealthinvest Partners Ab Increased Anika Therapeutics INC (NASDAQ:ANIK) by $4.91 Million as Shares Rose - CCH Daily News - Healthinvest Partners Ab Increased Anika Therapeutics INC (NASDAQ:ANIK) by $4.91 Million as Shares RoseCCH Daily NewsAnders Hallberg increased its stake in Anika Therapeutics Inc (NASDAQ:ANIK) by 29.46% based on its latest 2016Q1 regulatory filing with the SEC. Healthinvest Partners Ab bought 111,586 shares as the company's stock rose 17.44% with the market.Anika Therapeutics Inc. (NASDAQ:ANIK) Updated Analyst CoverageRisers & FallersAnika Therapeutics Inc. (NASDAQ:ANIK) Reports Yearly Sales Estimate At $114.76Equities FocusHold Calls Count For Anika Therapeutics Inc. (NASDAQ:ANIK) At 1RealistInvestor.comThe Postall 7 news articles »
05/27/16 11:00 AM3 Small Biotechs That Look Very Healthy -
05/25/16 09:51 PMHold Calls Count For Anika Therapeutics Inc. (NASDAQ:ANIK) At 1 - RealistInvestor.com - Hold Calls Count For Anika Therapeutics Inc. (NASDAQ:ANIK) At 1RealistInvestor.comBuy calls count on Anika Therapeutics Inc. (NASDAQ:ANIK)'s stock stands at 0 while Sell recommendations is 0. Hold recommendation is 1. Anika Therapeutics Inc. (NASDAQ:ANIK) has a total of 2 Strong Buy recommendations and 0 Strong Sell advises as of ...Portolan Capital Management LLC Decreased Stake in Anika Therapeutics INC (NASDAQ:ANIK) by $15.74 Million as ...CCH Daily NewsAnika Therapeutics Inc. (NASDAQ:ANIK) Current Deferred Tax Assets At $0.659 MillionsVanguard Tribuneall 3 news articles »
05/25/16 04:49 PMEurope Viscosupplementation Market Analysis and Opportunity Assessment 2016-2026 - Key manufacturers included in the report are Anika Therapeutics Inc., Sanofi S.A., Zimmer Biomet Holdings, Meda AB, Ferring B.V, Fidia Pharmaceutici S.p.A and Bioventus LLC. About MRRSE MRRSE stands for Market Research Reports Search Engine, the largest ...
05/23/16 07:28 AMAnika Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : ANIK-US : May 23, 2016 -
05/21/16 08:12 AMPortolan Capital Management LLC Decreased Stake in Anika Therapeutics INC (NASDAQ:ANIK) by $15.74 Million as ... - CCH Daily News - Portolan Capital Management LLC Decreased Stake in Anika Therapeutics INC (NASDAQ:ANIK) by $15.74 Million as ...CCH Daily NewsGeorge Mccabe decreased its stake in Anika Therapeutics Inc. (NASDAQ:ANIK) by 73.2% based on its latest 2016Q1 regulatory filing with the SEC. Portolan Capital Management Llc sold 357,656 shares as the company's stock rose 17.44% with the market.
05/19/16 10:00 PMBRIEF-Anika Therapeutics announces Canadian launch of cingal - Reuters - BRIEF-Anika Therapeutics announces Canadian launch of cingalReutersMay 19 Anika Therapeutics Inc. * Announces Canadian launch of cingal for the treatment of pain associated with osteoarthritis of the knee. * Cingal will be marketed and sold in Canada by Pendopharm, a division of Pharmascience Inc, a Quebec-based ...
05/19/16 04:55 PMAnika Therapeutics (ANIK) Launches CINGAL in Canada - StreetInsider.com - Anika Therapeutics (ANIK) Launches CINGAL in CanadaStreetInsider.comAnika Therapeutics, Inc., (NASDAQ: ANIK) announced the commercial launch of CINGAL®, its third-generation viscosupplement, in Canada. CINGAL received Health Canada approval in October 2015 to treat pain associated with osteoarthritis of the knee.Anika Therapeutics Inc. (NASDAQ:ANIK) - Broker UpdateRisers & FallersAnika Therapeutics Announces Canadian Launch of CINGAL for the Treatment of Pain Associated with Osteoarthritis of ...Business Wire (press release)all 3 news articles »
05/19/16 10:02 AMAnika Therapeutics Announces Canadian Launch of CINGAL for the Treatment of Pain Associated with Osteoarthritis of the Knee - [at noodls] - c487529d-3f2e-49e1-886d-00bb730d6921.pdf May 19, 2016 BEDFORD, Mass.--(BUSINESS WIRE)-- Anika Therapeutics, Inc., (NASDAQ: ANIK), a global, integrated orthopedics medicines company specializing in therapeutics ...
05/18/16 04:51 PMLatest Analyst Ratings For Anika Therapeutics Inc. (NASDAQ:ANIK) - Share Trading News - Latest Analyst Ratings For Anika Therapeutics Inc. (NASDAQ:ANIK)Share Trading News05/09/2016 – Anika Therapeutics Inc. had its “buy” rating reiterated by analysts at Singular Research. They now have a USD 60 price target on the stock. 04/27/2016 – Anika Therapeutics Inc. was downgraded to “market perform” by analysts at Northland ...and more »
05/17/16 04:43 PMAnika Therapeutics Inc. (NASDAQ:ANIK) One-Year Price Projection At $54 - Investor Newswire - Anika Therapeutics Inc. (NASDAQ:ANIK) One-Year Price Projection At $54Investor NewswireSell-side analysts are certain on the prospect of Anika Therapeutics Inc. (NASDAQ:ANIK) stock. As of 2016-05-16, the stock ABR stands at 1.67. This type of rating states that whenever a stock has a score of 5, investors should avoid investing in such ...and more »
05/16/16 04:35 PMAlpha One Assigns Impact Score Of 0 To Anika Therapeutics Inc. (NASDAQ:ANIK) - Investor Newswire - Alpha One Assigns Impact Score Of 0 To Anika Therapeutics Inc. (NASDAQ:ANIK)Investor NewswireAlpha One analyzed the various web articles published on Anika Therapeutics Inc. (NASDAQ:ANIK), and thereafter it gave company a daily sentiment score of 0.685. The entity designs algorithm based assessment to known stock sentiment on stock after ...and more »
05/14/16 03:26 AMHow Many Anika Therapeutics Inc (NASDAQ:ANIK)'s Analysts Are Bullish? - Wall Street Hints and News - How Many Anika Therapeutics Inc (NASDAQ:ANIK)'s Analysts Are Bullish?Wall Street Hints and NewsOut of 4 analysts covering Anika Therapeutics (NASDAQ:ANIK), 3 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 75% are positive. Anika Therapeutics has been the topic of 6 analyst reports since July 30, 2015 according to StockzIntelligence Inc ...and more »
05/13/16 03:28 AMBroker Outlook For Anika Therapeutics Inc. (NASDAQ:ANIK) - Share Trading.News - Share Trading News - Broker Outlook For Anika Therapeutics Inc. (NASDAQ:ANIK) - Share Trading.NewsShare Trading NewsAnika Therapeutics Inc. (NASDAQ:ANIK) has increased by +33.15% over 12 months. Anika Therapeutics, Inc. develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. The Company's products are based on ...
05/12/16 10:20 PMViscosupplementation Market: Europe Industry Analysis and Opportunity Assessment, 2016-2026 - Key manufacturers included in the report are Anika Therapeutics Inc., Sanofi S.A., Zimmer Biomet Holdings, Meda AB, Ferring B.V, Fidia Pharmaceutici S.p.A and Bioventus LLC. Braun Melsungen AG.
05/10/16 05:10 PMAnika Therapeutics Inc. (NASDAQ:ANIK) One-Year Mean Price Target At $51 - Investor Newswire - Anika Therapeutics Inc. (NASDAQ:ANIK) One-Year Mean Price Target At $51Investor NewswireSell-side analysts are confident on the future outlook of Anika Therapeutics Inc. (NASDAQ:ANIK) stock. As of 2016-05-09, the stock has an ABR of 2 rating, where number 5 denotes a Strong Sell and 1 Strong Buy. The ABR is reached on the basis of ...and more »
05/10/16 12:04 PMANIKA THERAPEUTICS, INC. Financials -
05/09/16 05:05 PMAnika Therapeutics Inc. (NASDAQ:ANIK) Latest Impact Score At 33 - Investor Newswire - Anika Therapeutics Inc. (NASDAQ:ANIK) Latest Impact Score At 33Investor NewswireAnika Therapeutics Inc. (NASDAQ:ANIK) has a 0.653 daily sentiment score given by Alpha One after scanning articles on various online news platform. Alpha One performs algorithm based analysis to reach stock sentiment based on content published on ...and more »
05/06/16 03:46 PMTop Mutual Funds Build Up Their Portfolios With China Lodging Group -
05/05/16 05:28 PMBroker Roundup For Anika Therapeutics Inc. (NASDAQ:ANIK) - Share Trading News - Broker Roundup For Anika Therapeutics Inc. (NASDAQ:ANIK)Share Trading News02/26/2016 – Anika Therapeutics Inc. had its “outperform” rating reiterated by analysts at Barrington Research. They now have a USD 49 price target on the stock. 08/27/2015 – First Analysis began new coverage on Anika Therapeutics Inc. giving the ...and more »
05/03/16 03:10 PMANIKA THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report -
05/02/16 05:31 PMAnika Therapeutics Inc. (NASDAQ:ANIK) Updated Broker Price Targets - Share Trading News - Anika Therapeutics Inc. (NASDAQ:ANIK) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Anika Therapeutics Inc. (NASDAQ:ANIK). The latest reports which are currently in issue on Monday 2nd of May state 0 analysts have a rating of “strong buy”, 0 analysts ...and more »
05/02/16 05:31 PMAnika Therapeutics Inc. (NASDAQ:ANIK) Boasts An Average Rating Of 3.75 - Investor Newswire - Anika Therapeutics Inc. (NASDAQ:ANIK) Boasts An Average Rating Of 3.75Investor NewswireAlpha One applies algorithm-based analytics for assessing a stock sentiment as per the published released on web channels. In this evaluation process, the group accesses the most relevant news platforms on a daily basis. Anika Therapeutics Inc.and more »
About Anika Therapeutics

Anika Therapeutics logoAnika Therapeutics, Inc. develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. The Company's products are based on hyaluronic acid (HA), a naturally occurring, biocompatible polymer found throughout the body. The Company's wholly owned subsidiary Anika S.r.l., has about 20 products commercialized primarily in Europe. These products are also all made from HA, based on two technologies: HYAFF, which is a solid form of HA and ACP gel, an autocross-linked polymer of HA. The Company's technologies for modifying the HA molecule allow product properties to be tailored specifically to therapeutic use. The Company offers therapeutic products from these technologies in the areas of: Orthobiologics, Dermal (Advanced wound care and Aesthetic dermatology), Surgical (Anti-adhesion and Ear, nose and throat care (ENT)), Ophthalmic and Veterinary.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Health Care Supplies
  • Exchange: NASDAQ
  • Symbol: ANIK
  • CUSIP: 03525510
Key Metrics:
  • Previous Close: $51.10
  • 50 Day Moving Average: $47.38
  • 200 Day Moving Average: $43.05
  • P/E Ratio: 22.91
  • P/E Growth: 1.89
  • Market Cap: $732.12M
  • Current Quarter EPS Consensus Estimate: $1.80 EPS
Additional Links:
Anika Therapeutics (NASDAQ:ANIK) Chart for Sunday, June, 26, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha